Register Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.98M Buy
11,849
+192
+2% +$41.3K 0.91% 24
2026
Q1
$2.54M Sell
11,657
-94
-0.8% -$20.9K 0.94% 27
2025
Q4
$2.69M Sell
11,751
-54
-0.5% -$12.3K 1.05% 20
2025
Q3
$2.73M Buy
11,805
+5
+0% +$1.02K 1.08% 22
2025
Q2
$2.19M Sell
11,800
-533
-4% -$99.1K 0.96% 29
2025
Q1
$2.58M Sell
12,333
-175
-1% -$34K 1.35% 14
2024
Q4
$2.22M Buy
12,508
+230
+2% +$42.3K 1.12% 21
2024
Q3
$2.42M Sell
12,278
-401
-3% -$74.8K 1.24% 18
2024
Q2
$2.17M Sell
12,679
-143
-1% -$23.7K 1.1% 19
2024
Q1
$2.33M Sell
12,822
-286
-2% -$49.3K 1.21% 15
2023
Q4
$2.03M Buy
13,108
+770
+6% +$112K 1.36% 17
2023
Q3
$1.84M Sell
12,338
-90
-0.7% -$13.2K 1.35% 16
2023
Q2
$1.67M Buy
12,428
+581
+5% +$85.2K 1.2% 17
2023
Q1
$1.89M Buy
11,847
+1,018
+9% +$156K 1.48% 14
2022
Q4
$1.75M Buy
+10,829
New +$1.66M 1.12% 18

Other funds holding ABBV

Register Financial Advisors's ABBV Position: Q2 2026 in Review

Register Financial Advisors increased its AbbVie (ABBV) stake by 1.6% in Q2 2026, buying an estimated $41.3K and bringing the position to 11,849 shares worth $2.98M. The position accounts for 0.91% of the portfolio, ranked #24.

Register Financial Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 2,132 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Register Financial Advisors held 11,849 shares of AbbVie worth $2.98M as of Q2 2026.
  • Register Financial Advisors bought 192 AbbVie shares in Q2 2026, an estimated $41.3K.
  • AbbVie made up 0.91% of Register Financial Advisors's portfolio in Q2 2026, its #24 holding.
  • Register Financial Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 2,132 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Register Financial Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.